Daiichi’s Quizartinib And The Quintessential 'Pazdur Moment'

 
• By Michael McCaughan
Richard Pazdur
He looks friendly enough, but sponsors should try to avoid getting into an ODAC with him. • Source: FDA photo by Michael J. Ermarth

More from US FDA Performance Tracker

More from Regulatory Trackers